Drug evaluation using patient-derived organoid of HER2-positive salivary duct carcinoma in vitro and in vivo

被引：0
|
作者：
Aoyama, Jun [1 ]
Nojima, Yusuke [1 ]
Aizawa, Yoshihiro [1 ]
Takada, Kentaro [1 ]
Kijima, Natsumi [1 ,2 ]
Hirai, Yuri [1 ]
Hatano, Takashi [1 ]
Takahashi, Hideaki [1 ]
Sano, Daisuke [1 ]
Fujii, Satoshi [2 ]
Oridate, Nobuhiko [1 ]
机构：
[1] Yokohama City Univ, Dept Head & Neck Surg, Yokohama, Kanagawa, Japan
[2] Yokohama City Univ, Dept Mol Pathol, Yokohama, Kanagawa, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-1287
引用
收藏
页码：449 / 449
页数：1
相关论文
共 50 条
  • [21] Using in vivo fluorescence lifetime imaging to detect HER2-positive tumors
    Ardeshirpour, Yasaman
    Sackett, Dan L.
    Knutson, Jay R.
    Gandjbakhche, Amir H.
    EJNMMI RESEARCH, 2018, 8
  • [22] Using in vivo fluorescence lifetime imaging to detect HER2-positive tumors
    Yasaman Ardeshirpour
    Dan L. Sackett
    Jay R. Knutson
    Amir H. Gandjbakhche
    EJNMMI Research, 8
  • [23] Investigation of drug evaluation model using Patient-Derived Cells (PDC)
    Moriguchi, Misato
    Tsunesumi, Shinichiro
    Enoki, Shigenori
    Katayama, Seiichi
    Chiwaki, Fumiko
    Sasaki, Hiroki
    CANCER SCIENCE, 2023, 114 : 1840 - 1840
  • [24] HER2/HER3-positive metastatic salivary duct carcinoma in the pleural effusion: A case report
    Murata, Kazuya
    Kawahara, Akihiko
    Ono, Takeharu
    Takase, Yorihiko
    Abe, Hideyuki
    Naito, Yoshiki
    Akiba, Jun
    DIAGNOSTIC CYTOPATHOLOGY, 2018, 46 (05) : 429 - 433
  • [25] Effects of Lapatinib on HER2-Positive and HER2-Negative Canine Mammary Carcinoma Cells Cultured In Vitro
    Leis-Filho, Antonio Fernando
    de Faria Lainetti, Patricia
    Emiko Kobayashi, Priscila
    Fonseca-Alves, Carlos Eduardo
    Laufer-Amorim, Renee
    PHARMACEUTICS, 2021, 13 (06)
  • [26] Rapid Processing and Drug Evaluation in Glioblastoma Patient-Derived Organoid Models with 4D Bioprinted Arrays
    Chadwick, Michelle
    Yang, Chen
    Liu, Liqiong
    Gamboa, Christian Moya
    Jara, Kelly
    Lee, Howon
    Sabaawy, Hatem E.
    ISCIENCE, 2020, 23 (08)
  • [27] Neratinib plus dasatinib is highly synergistic in HER2-positive breast cancer in vitro and in vivo
    Conlon, Neil
    Roche, Sandra
    Mahdi, Amira F.
    Browne, Alacoque
    Breen, Laura
    Gaubatz, Johanna
    Meiller, Justine
    O'Neill, Fiona
    O'Driscoll, Lorraine
    Cremona, Mattia
    Hennessy, Bryan
    Eli, Lisa
    Crown, John
    Collins, Denis M.
    TRANSLATIONAL ONCOLOGY, 2024, 49
  • [28] HER2-directed therapies beyond progression in a patient with recurrent HER2-positive mucinous ovarian carcinoma
    Chan, Jack Junjie
    Wang, Junjie
    ANNALS OF ONCOLOGY, 2023, 34 : S1464 - S1464
  • [29] Noonan Syndrome Patient-Derived iPSCs: An in vitro Model for Drug Testing and Evaluation of Disorders
    Rajasingh, Sheeja
    Panda, Arunima
    Isai, Dona G.
    Samanta, Saheli
    Burkey, Kyley K.
    Czirok, Andras
    Rajasingh, Johnson
    CIRCULATION, 2018, 138
  • [30] 64Cu-DOTA-trastuzumab imaging in a HER2-positive intracranial patient-derived xenograft (PDX) model of breast cancer metastasis
    Kristensen, Lotte
    Nielsen, Carsten
    Nedergaard, Mette
    Knudsen, Camilla
    Christensen, Camilla
    Wick, Michael
    Papadopoulos, Kyri
    Tolcher, Anthony
    Kjaer, Andreas
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
12345